Romanian Pharmaceutical Sector -Between Challenges, Opportunities and Market Threats. Legal Aspects of the Trading of Listed Companies

Abstract

Companies operating in the health and medical sciences will face this year not only with the challenges of an increasingly globalized market, but also with specific problems, both regional and national. While other large sectors, such as the food industry, are poorly represented on the Romanian stock market, the pharmaceutical sector is represented by the following six companies: Antibiotics, Biofarm, Farmaceutica Remedia, MedLife, Zentiva and Ropharma. During 2014-2016, these companies recorded oscillatory developments in sales and the net result of the year, as a result of the price reduction for drugs, the need for law to separate wholesale distribution from wholesale, a significant reduction in discounts to distributors, with an important negative impact on their margin. Globally, the pharmaceutical market is estimated to over $ 1 trillion, according the outcomes in 2016, while the top 15 companies accounting represent about 40% of the total.